Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy

Gene Therapy

Volumn 6, Issue 2, 1999, Pages 198-208

  De Felipe, P ^a   Martin V ^a   Cortes M L ^a   Ryan, M ^b   Izquierdo, M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Bicistronic retroviral vectors; FMDV 2A; Gene therapy; HSV1tk; pac

Indexed keywords

MESSENGER RNA; NUCLEOTIDE; PLASMID VECTOR; PROTEIN;

ANIMAL CELL; ARTICLE; EXPRESSION VECTOR; FOOT AND MOUTH DISEASE VIRUS; GENE THERAPY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RNA TRANSLATION;

3T3 CELLS; ACETYLTRANSFERASES; ANIMALS; ANTIVIRAL AGENTS; APHTHOVIRUS; BLOTTING, WESTERN; CHIMERA; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GENOME, VIRAL; HUMANS; MICE; PLASMIDS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0033030109     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300811     Document Type: Article

References (25)

1. Brown AMC, Dougherty JP. Retroviral vectors. In: Glover DM, Hames BD (eds). DNA Cloning, vol 4. Oxford University Press: Oxford, 1995, pp 113-142.
2. Wimmer E et al. Genetics of poliovirus. Annu Rev Genet 1993; 27: 353-436.
3. Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Ann Rev Microbiol 1990; 44: 603-623.
4. Ryan MD, Flint M. Virus-encoded proteinases of the picornavirus super-group. J Gen Virol 1997; 78: 699-723.
5. Palmenberg AC et al. Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors. Virology 1992; 190: 754-762.
6. Donnelly MLL et al. The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol 1997; 78: 13-21.
7. Michiels T et al. Protein 2A is not required for Theiler's virus replication. J Virol 1997; 71: 9549-9556.
8. Hahn H, Palmenberg AC. Mutational analysis of the encephalomyocarditis virus primary cleavage. J Virol 1996; 70: 6870-6875.
9. Devaney MA et al. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 1988; 62: 4407-4409.
10. Medina M et al. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 1993; 194: 355-359.
11. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 1994; 13: 928-933.
12. Percy N et al. Expression of a foreign protein by influenza A virus. J Virol 1994; 68: 4486-4492.
13. Schmidt M, Rethwilm A. Replicating foamy virus-based vectors directing high level expression of forcing genes. J Virol 1995; 210: 167-178.
14. Miller D, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-988.
15. Schwartz F et al. A dominant positive and negative selectable gene for use in mammalian cells. Proc Natl Acad Sci USA 1991; 88: 10416-10420.
16. Veelken H et al. Systematic evaluation of chimeric marker genes on dicistronic transcription units for regulated expression of transgenes in vitro and in vivo. Hum Gen Ther 1996; 7: 1827-1836.
17. Lupton SD et al. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol 1991; 11: 3374-3378.
18. Morgenstern J, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acid Res 1990; 18: 3587-3596.
19. Dirks W et al. Dicistronic transcription units for gene expression in mammalian cells. Gene 1993; 128: 247-249.
20. Sugimoto Y et al. Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site. Bio/Technology 1994; 12: 694-698.
21. Roosien J et al. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol 1990; 71: 1703-1711.
22. Morgan RA et al. Retroviral vector containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acid Res 1992; 20: 1293-1299.
23. Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol 1995; 154: 6466-6474.
24. Hughes SH et al. Adaptor plasmid simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol 1987; 61: 3004-3012.
25. Izquierdo M et al. Gene therapy in brain tumours: implication of the size of glioblastoma on its curability. Acta Neurochir 1997; 68 (suppl): 111-117.